Multiple-dose pharmacokinetics and safety of rufloxacin in normal volunteers.
The pharmacokinetics and safety of rufloxacin were evaluated in a double-blind, placebo-controlled study. Two groups of 16 healthy volunteers were given a single oral loading dose of 400 or 600 mg of rufloxacin on day 1 of the study. A single daily maintenance dose of 200 or 300 mg was then administ...
Guardat en:
| Publicat a: | Antimicrob Agents Chemother |
|---|---|
| Autors principals: | , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society for Microbiology (ASM)
1992
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC190335/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/1329618/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.36.6.1296 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|